A PHASE II LYSA STUDY OF OBINUTUZUMAB COMBINED WITH LENALIDOMIDE FOR RELAPSED OR REFRACTORY FOLLICULAR B‐CELL LYMPHOMA. (June 2017) - Morschhauser, F.; Le Gouill, S.; Feugier, P.; Van Den Neste, E.; Nicolas‐Virelizier, E.; Bijou, F.; Salles, G.A.; Tilly, H.; Van Eygen, K.; Van Hoof, A.; Bonnet, C.; Haioun, C.; et al.